Cytotoxic Activity of Compounds from Styrax obassia.
Nat Prod Commun
; 12(2): 259-260, 2017 Feb.
Article
em En
| MEDLINE
| ID: mdl-30428225
ABSTRACT
Cancer is a major public health burden in both developed and developing countries. Plant-derived compounds have played an important role in the development of useful anti-cancer agents. The current study was designed to evaluate the cytotoxic activity of chemical compounds from the stem bark of Styrax obassia. Seven known compounds (1-7) were isolated and identified. Compound 2 exhibited cytotoxic activity against the breast cancer cell line MCF-7 with an IC550 of 27.9 µM, followed by the human cervical cancer cell line Hela with an IC50 of 23.3 µM, and the human promyelocytic leukemia cell line HL-60 with an IC50 of 47.8 RM. Compound 7 exhibited cytotoxicity against Hela cells with an ICso of 16.8 pM, followed by MCF-7 cells with an IC50 of 53.5 µM. This is the first study to investigate the significant anti-tumor properties of isolated compounds from the stem bark of S. obassia.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Styrax
/
Antineoplásicos Fitogênicos
Limite:
Humans
Idioma:
En
Revista:
Nat Prod Commun
Assunto da revista:
BOTANICA
/
FARMACOLOGIA
/
QUIMICA
Ano de publicação:
2017
Tipo de documento:
Article